Association between plasma trimethylamine N-oxide and coronary heart disease: new insights on sex and age differences
Authors:
Open Access
- 7 October 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1397023
Abstract
Aim: Elevated plasma trimethylamine N-oxide (TMAO) is related to atherosclerosis. Whether the relationship of TMAO and coronary heart disease (CHD) is influenced by sex or age is uncertain. We aim to explore the sex and age differences in the relationship between plasma TMAO and CHD risk and severity.Methods: A case–control study was conducted in patients undergoing elective coronary angiography. Matched by sex, age (±2 years), and operation date (±180 days), a total of 429 CHD case–control pairs were included. Plasma TMAO was quantified using liquid chromatography–tandem mass spectrometry. Logistic regression analyses were performed to evaluate the association between plasma TMAO and CHD risk and severity.Results: The overall median (interquartile range) plasma TMAO level was 0.11 (0.06–0.18) μg/ml. After stratification by sex and age, and adjustment for common CHD risk factors, the association between TMAO and CHD risk was significant in the older (≥65 years) male subgroup [odds ratios (OR) = 1.57, 95% confidence interval (CI): 1.09–2.28, P = 0.016], but not in other sex–age subgroups (all P > 0.05). The relationship of plasma TMAO and CHD risk was modified by age (adjusted Pinteraction = 0.001) in male individuals. Plasma TMAO was also associated with a higher risk of multi-vessel disease in male patients with CHD (OR = 1.65, 95% CI: 1.18–2.32, P = 0.004), but not in females.Conclusions: Plasma TMAO is significantly positively associated with the risk and severity of CHD in Chinese men. Age has an interactive effect on the relationship between plasma TMAO and CHD risk in men. Our findings warrant further investigation.Keywords
This publication has 35 references indexed in Scilit:
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- The Global Burden of Cardiovascular Diseases and Risk FactorsJACC, 2019
- Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomographyInternational Journal of Cardiology, 2018
- Plasma Trimethylamine N -Oxide, a Gut Microbe–Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic BurdenJACC, 2016
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis RiskCell, 2016
- Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of AtherosclerosisCell, 2015
- Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessmentThe Lancet Global Health, 2015
- Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometryAnalytical Biochemistry, 2014
- Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary RegulationCell Metabolism, 2013
- Dietary Intake Patterns and Sociodemographic Factors in the Atherosclerosis Risk in Communities StudyPreventive Medicine, 1994